Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 16, 2019

SELL
$0.02 - $0.06 $3,326 - $9,979
-166,333 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$0.02 - $0.04 $26 - $52
-1,316 Reduced 0.78%
166,333 $5,000
Q3 2017

Nov 16, 2017

BUY
$0.06 - $0.07 $10,058 - $11,735
167,649
167,649 $12,000

About MYMETICS CORP


  • Ticker MYMX
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 303,758,016
  • Description
  • Mymetics Corporation, a vaccine company, engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, malaria, and chikungunya. Mymetics Corporatio...
More about MYMX
Track This Portfolio

Track Tanaka Capital Management Inc Portfolio

Follow Tanaka Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tanaka Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tanaka Capital Management Inc with notifications on news.